Anti-HMGB1 neutralizing antibody also significantly decreases the effect of released extracellular HMGB1 from cancer-associated fibroblasts or recombinant HMGB1 on doxorubicin (DOX) resistant breast cancer cells [114]. The gene discussed is HMGB1; the disease is cancer.